Catalog of exogenous risk factors for bladder carcinogenesis.
Journal
Current opinion in urology
ISSN: 1473-6586
Titre abrégé: Curr Opin Urol
Pays: United States
ID NLM: 9200621
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
The aim of this article is to provide an overview of recent findings regarding the risk factors for bladder cancer. Most of the available data derive from retrospective analysis. Smoking represents the most common and important risk factor. Occupational, dietary, and environmental exogenic carcinogen exposure, as well as several lifestyle factors, can increase the risk of developing bladder cancer. Bladder cancer is a common malignancy worldwide. Cigarette smoking, exposure to aromatic amines and arsenic are known risk factors for bladder cancer. Evidence on other modifiable risk factors such as carcinogen exposure derived from the diet or environment as well as occupational hazards is still weak. Medical conditions leading to chronic inflammation, altering insulin resistance, negatively modulating the immune system and/or genetic alterations may have a role in bladder cancer carcinogenesis. Further studies are, however, necessary to identify possible exogenic risk factors, as well as their interactions, that partake in the carcinogenesis of bladder cancer.
Identifiants
pubmed: 32235283
doi: 10.1097/MOU.0000000000000753
pii: 00042307-202005000-00026
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
449-456Références
Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017; 71:96–108.
Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63:234–241.
Richters A, Aben KK, Kiemeney LA. The global burden of urinary bladder cancer: an update. World J Urol 2019. 1–10.
Cumberbatch MG, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol 2018; 74:784–795.
Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 2016; 70:458–466.
Kispert S, Marentette J, McHowat J. Cigarette smoking promotes bladder cancer via increased platelet-activating factor. Physiol Rep 2019; 7:e13981.
Pezzuto A, Citarella F, Croghan I, Tonini G. The effects of cigarette smoking extracts on cell cycle and tumor spread: novel evidence. Fut Sci OA 2019; 5:FSO394.
Stern MC, Lin J, Figueroa JD, et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 2009; 69:6857–6864.
Barbosa AL, Vermeulen SH, Aben KK, et al. Smoking intensity and bladder cancer aggressiveness at diagnosis. PLoS One 2018; 13:e0194039.
Rink M, Crivelli JJ, Shariat SF, et al. Smoking and bladder cancer: a systematic review of risk and outcomes. Eur Urol Focus 2015; 1:17–27.
Crivelli JJ, Xylinas E, Kluth LA, et al. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol 2014; 65:742–754.
Rink M, Zabor EC, Furberg H, et al. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol 2013; 64:456–464.
Rink M, Furberg H, Zabor EC, et al. Impact of smoking and smoking cessation on oncologic outcomes in primary nonmuscle-invasive bladder cancer. Eur Urol 2013; 63:724–732.
Rink M, Xylinas E, Babjuk M, et al. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. J Urol 2012; 188:2120–2127.
Boeri L, Soligo M, Frank I, et al. Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience. BJU Int 2019; 123:1011–1019.
Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tobacco Res 2014; 17:704–709.
Kotandeniya D, Carmella SG, Pillsbury ME, Hecht SS. Combined analysis of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users. J Chromatogr B 2015; 1007:121–126.
Fuller TW, Acharya AP, Meyyappan T, et al. Comparison of bladder carcinogens in the urine of e-cigarette users versus non e-cigarette using controls. Sci Rep 2018; 8:507.
Shariat SF. Electronic cigarettes: a wolf in sheep's clothing. Eur Urol 2017; 71:924–925.
Rouprêt M, Babjuk M, Compérat E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 2018; 73:111–122.
Sciannameo V, Carta A, d’Errico A, et al. New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies. Int Arch Occup Environ Health 2019; 92:347–359.
Colin R, Grzebyk M, Wild P, et al. Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories. Occup Environ Med 2018; 75:328–336.
Jalilian H, Ziaei M, Weiderpass E, et al. Cancer incidence and mortality among firefighters. Int J Cancer 2019.
Boniol M, Koechlin A, Boyle P. Meta-analysis of occupational exposures in the rubber manufacturing industry and risk of cancer. Int J Epidemiol 2017; 46:1940–1947.
Nakano M, Omae K, Takebayashi T, et al. An epidemic of bladder cancer: ten cases of bladder cancer in male Japanese workers exposed to ortho-toluidine. J Occup Health 2018; 60:307–311.
Fankhauser CD, Mostafid H. Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle. Curr Opin Urol 2018; 28:88–92.
Lippi G, Del Rio D. Nutritional habits and bladder cancer. Transl Androl Urol 2018; 7: (Suppl. 1): S90.
Crippa A, Larsson SC, Discacciati A, et al. Red and processed meat consumption and risk of bladder cancer: a dose-response meta-analysis of epidemiological studies. Eur J Nutr 2018; 57:689–701.
WCRFAIfC ResearchContinuous update project report: food, nutrition, physical activity, and the prevention of colorectal cancer. Washington, DC: American Institute for Cancer Research; 2011.
Bingham SA, Hughes R, Cross AJ. Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. J Nutr 2002; 132:3522S–3525S.
Bertram J, Craig A. Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur J Cancer 1972; 8:587–594.
Okada M, Ishidate M. Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues: selective induction of urinary bladder tumours in the rat. Xenobiotica 1977; 7:11–24.
Rosato V, Negri E, Serraino D, et al. Processed meat and risk of renal cell and bladder cancers. Nutr Cancer 2018; 70:418–424.
Barry KH, Jones RR, Cantor KP, et al. Ingested nitrate and nitrite and bladder cancer in Northern New England. Epidemiology 2020; 31:136–144.
Al-Zalabani AH, Stewart KF, Wesselius A, et al. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 2016; 31:811–851.
Di Maso M, Turati F, Bosetti C, et al. Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer. Cancer Epidemiol 2019; 63:101595.
Westhoff E, de Oliveira-Neumayer JM, Aben KK, et al. Low awareness of risk factors among bladder cancer survivors: new evidence and a literature overview. Eur J Cancer 2016; 60:136–145.
Abufaraj M, Tabung FK, Shariat SF, et al. Association between inflammatory potential of diet and bladder cancer risk: results of three United States prospective cohort studies. J Urol 2019; 10.1097/JU.0000000000000279.
Dai Z-W, Cai KD, Li F-R, et al. Association between coffee consumption and risk of bladder cancer in a meta-analysis of 16 prospective studies. Nutr Metab 2019; 16:66.
Yu EY, Wesselius A, van Osch F, et al. The association between coffee consumption and bladder cancer in the bladder cancer epidemiology and nutritional determinants (BLEND) international pooled study. Cancer Causes Control 2019; 30:859–870.
Vartolomei MD, Iwata T, Roth B, et al. Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis. World J Urol 2019. 1–12.
Boffetta P, Borron C. Low-level exposure to arsenic in drinking water and risk of lung and bladder cancer: a systematic review and dose–response meta-analysis. Dose Response 2019; 17:1559325819863634.
Tsuji JS, Chang ET, Gentry PR, et al. Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach. Crit Rev Toxicol 2019; 49:36–84.
Karagas MR, Punshon T, Davis M, et al. Rice intake and emerging concerns on arsenic in rice: a review of the human evidence and methodologic challenges. Curr Environ Health Rep 2019; 6:361–372.
Turner MC, Gracia-Lavedan E, Cirac M, et al. Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study. Int J Cancer 2019; 145:894–900.
Hameed DA, Yassa HA, Agban MN, et al. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure. Environ Sci Pollut Res 2018; 25:21535–21542.
Desbiolles A, Roudier C, Goria S, et al. Cancer incidence in adults living in the vicinity of nuclear power plants in France, based on data from the French Network of Cancer Registries. Int J Cancer 2018; 142:899–909.
Rosiello G, Palumbo C, Knipper S, et al. Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer. Urologic oncology 2020; 38:76.e1–e9.
Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012; 35:2402–2411.
Montella M, Di Maso M, Crispo A, et al. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study. BMC Cancer 2015; 15:720.
Lenis AT, Asanad K, Blaibel M, et al. Association between metabolic syndrome and recurrence of nonmuscle invasive bladder cancer following bacillus Calmette-Guérin treatment. Urol Pract 2018; 5:132–138.
Nagase K, Tobu S, Kusano S, et al. The association between metabolic syndrome and high-stage primary urothelial carcinoma of the bladder. Curr Urol 2018; 12:39–42.
Ko SH, Han K, Yun JS, et al. Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study. Eur J Endocrinol 2019; 181:489–498.
Zhu Z, Wang X, Shen Z, et al. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer 2013; 13:310.
Dankner R, Roth J. More recent, better designed studies have weakened links between antidiabetes medications and cancer risk. Diabetic medicine: a journal of the British Diabetic Association 2020; 37:194–202.
Hu J, Chen JB, Cui Y, et al. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Medicine 2018; 97:e11596.
Turati F, Galeone C, Augustin LS, La Vecchia C. Glycemic index, glycemic load and cancer risk: an updated meta-analysis. Nutrients 2019; 11:2342.
Nesi G, Galli IC, Amorosi A, Santi R. Environment and urinary bladder cancer: a historical perspective. Pol J Pathol 2019; 70:21–25.
Ishida K, Hsieh MH. Understanding urogenital schistosomiasis-related bladder cancer: an update. Front Med (Lausanne) 2018; 5:223.
Nesi G, Nobili S, Cai T, et al. Chronic inflammation in urothelial bladder cancer. Virchows Arch 2015; 467:623–633.
Pottegard A, Kristensen KB, Friis S, et al. Urinary tract infections and risk of squamous cell carcinoma bladder cancer: a Danish nationwide case-control study. Int J Cancer 2020; 146:1930–1936.
Vermeulen SH, Hanum N, Grotenhuis AJ, et al. Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 2015; 112:594–600.
Bayne CE, Farah D, Herbst KW, Hsieh MH. Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis. World J Urol 2018; 36:1181–1190.
West DA, Cummings JM, Longo WE, et al. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 1999; 53:292–297.